scispace - formally typeset
E

Elizabeth A. Grimm

Researcher at University of Texas MD Anderson Cancer Center

Publications -  247
Citations -  17620

Elizabeth A. Grimm is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Melanoma & Cytotoxic T cell. The author has an hindex of 65, co-authored 241 publications receiving 16582 citations. Previous affiliations of Elizabeth A. Grimm include Children's Hospital of Philadelphia & University of Texas System.

Papers
More filters
Journal ArticleDOI

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

TL;DR: Evidence is presented that the LAK system is a phenomenon distinct from either NK or CTL systems that probably accounts for a large number of reported nonclassical cytotoxicities and may be functional in immune surveillance against human solid tumors.
Journal ArticleDOI

Biological activity of recombinant human interleukin-2 produced in Escherichia coli

TL;DR: The recombinant lymphokine supports the growth of murine and human interleukin-2 dependent cell lines, enhances the generation of cytolytic cells in vitro and in vivo after alloimmunization, and generates lymphokin activated killer cells from murineand human lymphocytes.
Journal ArticleDOI

Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma

A. Gordon Robertson, +173 more
- 14 Aug 2017 - 
TL;DR: Within D3-UM, EIF1AX- and SRSF2/SF3B1-mutant tumors have distinct somatic copy number alterations and DNA methylation profiles, providing insight into the biology of these low- versus intermediate-risk clinical mutation subtypes.
Journal ArticleDOI

The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses

TL;DR: The immune performance and interactions of CNS microglia/macrophages in glioma patients were studied in this article, where the authors found that microglias were the predominant immune cell infiltrating gliomas (~ 1% of total cells); others identified were myeloid dendritic cells (DCs), plasmacytoid DCs, and T cells.
Journal Article

Induction of Chemosensitivity in Human Lung Cancer Cells in Vivo by Adenovirus-mediated Transfer of the Wild-Type p53 Gene

TL;DR: Results support the clinical application of a regimen combining gene replacement using replication-deficient wild-type p53 adenovirus and DNA-damaging drugs for treatment of human cancer.